Stock data
Fennec Pharmaceuticals Inc. (FENC)
Fennec Pharmaceuticals Inc. (FENC) reported revenue of US$44.64M and net income of -US$9.74M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$44.64M | — | -US$6.28M | -US$9.74M | — |
| 2024 | US$47.54M | — | US$2.57M | -US$0.44M | — |
| 2023 | US$21.25M | US$19.99M | -US$12.77M | -US$16.05M | — |
| 2022 | US$1.53M | US$1.45M | -US$22.59M | -US$23.71M | — |
| 2021 | — | — | -US$17.22M | -US$17.35M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$17.87M | US$1.97M | — |
| 2026-03-31 | US$15.11M | US$0.20M | — |
| 2025-12-31 | US$13.78M | -US$4.79M | — |
| 2025-09-30 | US$12.46M | -US$0.64M | — |
| 2025-06-30 | US$9.65M | -US$3.15M | — |
| 2025-03-31 | US$8.75M | -US$1.17M | — |
| 2024-12-31 | US$7.92M | -US$1.99M | — |
| 2024-09-30 | US$6.97M | -US$5.74M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.